RxSight, Inc. (RXST) Debt-to-equity % [USD] 2022 - 2024

Historical data

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
RxSight, Inc. quarterly Debt-to-equity history and growth rate from 2022 to 2024.
  • RxSight, Inc. Debt-to-equity for the quarter ending March 31, 2024 was 15.5 %, a 70.8% decline year-over-year.
Debt-to-equity, Quarterly (% [USD])
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q1 2024 15.5 -37.6 -70.8% Mar 31, 2024
Q4 2023 22.1 -32.9 -59.8% Dec 31, 2023
Q3 2023 31.8 -16.3 -33.8% Sep 30, 2023
Q2 2023 44.2 +2.45 +5.87% Jun 30, 2023
Q1 2023 53.1 -165 -75.7% Mar 31, 2023
Q4 2022 55 Dec 31, 2022
Q3 2022 48.1 Sep 30, 2022
Q2 2022 41.7 Jun 30, 2022
Q1 2022 219 Mar 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.